These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 29490904)

  • 21. Correlation of high urinary Smad1 level with glomerular hyperfiltration in type 2 diabetes mellitus.
    Fu WJ; Fang YG; Deng RT; Wen S; Chen ML; Huang ZH; Tang HH; Xiong SL; Huang XZ; Wang Q
    Endocrine; 2013 Apr; 43(2):346-50. PubMed ID: 22798249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urinary peptidomics in a rodent model of diabetic nephropathy highlights epidermal growth factor as a biomarker for renal deterioration in patients with type 2 diabetes.
    Betz BB; Jenks SJ; Cronshaw AD; Lamont DJ; Cairns C; Manning JR; Goddard J; Webb DJ; Mullins JJ; Hughes J; McLachlan S; Strachan MWJ; Price JF; Conway BR
    Kidney Int; 2016 May; 89(5):1125-1135. PubMed ID: 27083286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histological Evidence of Diabetic Kidney Disease Precede Clinical Diagnosis.
    Comai G; Malvi D; Angeletti A; Vasuri F; Valente S; Ambrosi F; Capelli I; Ravaioli M; Pasquinelli G; D'Errico A; Fornoni A; La Manna G
    Am J Nephrol; 2019; 50(1):29-36. PubMed ID: 31167184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glomerular basement membrane duplication is a predictor of the prognosis of diabetic nephropathy in patients with type 2 diabetes.
    Yamakawa T; Kawaguchi T; Kitamura H; Kadomura M; Nishimura M; Yokoo T; Imasawa T
    Clin Exp Nephrol; 2019 Apr; 23(4):521-529. PubMed ID: 30467801
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Veiga G; Alves B; Perez M; Alcantara LV; Raimundo J; Zambrano L; Encina J; Pereira EC; Bacci M; Murad N; Fonseca F
    J Clin Pathol; 2020 Nov; 73(11):713-721. PubMed ID: 32184218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural involvement in type 1 and type 2 diabetic nephropathy.
    Dalla Vestra M; Saller A; Bortoloso E; Mauer M; Fioretto P
    Diabetes Metab; 2000 Jul; 26 Suppl 4():8-14. PubMed ID: 10922968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical verification of a novel urinary microRNA panal: 133b, -342 and -30 as biomarkers for diabetic nephropathy identified by bioinformatics analysis.
    Eissa S; Matboli M; Bekhet MM
    Biomed Pharmacother; 2016 Oct; 83():92-99. PubMed ID: 27470555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary Potassium Excretion and Renal and Cardiovascular Complications in Patients with Type 2 Diabetes and Normal Renal Function.
    Araki S; Haneda M; Koya D; Kondo K; Tanaka S; Arima H; Kume S; Nakazawa J; Chin-Kanasaki M; Ugi S; Kawai H; Araki H; Uzu T; Maegawa H
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2152-8. PubMed ID: 26563378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relationship between the thickness of glomerular basement membrane and renal outcomes in patients with diabetic nephropathy.
    Zhang J; Wang Y; Gurung P; Wang T; Li L; Zhang R; Li H; Guo R; Han Q; Zhang J; Lei S; Liu F
    Acta Diabetol; 2018 Jul; 55(7):669-679. PubMed ID: 29610978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diagnostic significance of urinary immunoglobulin G in diabetic nephropathy].
    Yashima I; Hirayama T; Shiiki H; Kanauchi M; Dohi K
    Nihon Jinzo Gakkai Shi; 1999 Dec; 41(8):787-96. PubMed ID: 10655727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical implication of urinary tubular markers in the early stage of nephropathy with type 2 diabetic patients.
    Kim SS; Song SH; Kim IJ; Yang JY; Lee JG; Kwak IS; Kim YK
    Diabetes Res Clin Pract; 2012 Aug; 97(2):251-7. PubMed ID: 22440044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High urinary sulfate concentration is associated with reduced risk of renal disease progression in type 2 diabetes.
    van den Born JC; Frenay AR; Bakker SJ; Pasch A; Hillebrands JL; Lambers Heerspink HJ; van Goor H
    Nitric Oxide; 2016 May; 55-56():18-24. PubMed ID: 26952289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Change and significance of urinary smad3 in type 2 diabetic nephropathy].
    Guo KF; Kou JX; Lu JX; Zhang L; Yu HY; Chen HB
    Zhonghua Yi Xue Za Zhi; 2013 Apr; 93(14):1067-71. PubMed ID: 23902838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and pathological predictors of estimated GFR decline in patients with type 2 diabetes and overt proteinuric diabetic nephropathy.
    Mise K; Hoshino J; Ueno T; Hazue R; Sumida K; Hiramatsu R; Hasegawa E; Yamanouchi M; Hayami N; Suwabe T; Sawa N; Fujii T; Hara S; Ohashi K; Takaichi K; Ubara Y
    Diabetes Metab Res Rev; 2015 Sep; 31(6):572-81. PubMed ID: 25533683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urinary platelet-derived growth factor-BB as an early marker of nephropathy in patients with type 2 diabetes: an Egyptian study.
    Bessa SS; Hussein TA; Morad MA; Amer AM
    Ren Fail; 2012; 34(6):670-5. PubMed ID: 22486214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paratubular basement membrane insudative lesions predict renal prognosis in patients with type 2 diabetes and biopsy-proven diabetic nephropathy.
    Mise K; Yamaguchi Y; Hoshino J; Ueno T; Sekine A; Sumida K; Yamanouchi M; Hayami N; Suwabe T; Hiramatsu R; Hasegawa E; Sawa N; Fujii T; Hara S; Sugiyama H; Makino H; Wada J; Ohashi K; Takaichi K; Ubara Y
    PLoS One; 2017; 12(8):e0183190. PubMed ID: 28813476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonalbumin proteinuria is a simple and practical predictor of the progression of early-stage type 2 diabetic nephropathy.
    Kim JH; Kim SS; Kim IJ; Lee MJ; Jeon YK; Kim BH; Song SH; Kim YK
    J Diabetes Complications; 2017 Feb; 31(2):395-399. PubMed ID: 27913013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of Endothelial Cell Injury Marker Cd146 Correlates with Disease Severity and Predicts the Renal Outcomes in Patients with Diabetic Nephropathy.
    Fan Y; Fei Y; Zheng L; Wang J; Xiao W; Wen J; Xu Y; Wang Y; He L; Guan J; Wei J; He JC; Wang N
    Cell Physiol Biochem; 2018; 48(1):63-74. PubMed ID: 30001528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased urinary miR-196a level predicts the progression of renal injury in patients with diabetic nephropathy.
    An Y; Zhang C; Xu F; Li W; Zeng C; Xie L; Liu Z
    Nephrol Dial Transplant; 2020 Jun; 35(6):1009-1016. PubMed ID: 30521014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Osteoinductive factor is a novel biomarker for the diagnosis of early diabetic nephropathy.
    Wang S; Wang Y; Zheng R; Zhao Z; Ma Y
    Int J Clin Exp Pathol; 2015; 8(3):3110-5. PubMed ID: 26045825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.